400 related articles for article (PubMed ID: 37190216)
1. Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy.
Kavun A; Veselovsky E; Lebedeva A; Belova E; Kuznetsova O; Yakushina V; Grigoreva T; Mileyko V; Fedyanin M; Ivanov M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190216
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
André T; Cohen R; Salem ME
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
[TBL] [Abstract][Full Text] [Related]
3. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
[TBL] [Abstract][Full Text] [Related]
4. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
Roudko V; Cimen Bozkus C; Greenbaum B; Lucas A; Samstein R; Bhardwaj N
Front Immunol; 2021; 12():757804. PubMed ID: 34630437
[TBL] [Abstract][Full Text] [Related]
5. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S; Roque DM; Siegel ER; Buza N; Hui P; Bonazzoli E; Guglielmi A; Zammataro L; Nagarkatti N; Zaidi S; Lee J; Silasi DA; Huang GS; Andikyan V; Damast S; Clark M; Azodi M; Schwartz PE; Tymon-Rosario JR; Harold JA; Mauricio D; Zeybek B; Menderes G; Altwerger G; Ratner E; Alexandrov LB; Iwasaki A; Kong Y; Song E; Dong W; Elvin JA; Choi J; Santin AD
Cancer; 2022 Mar; 128(6):1206-1218. PubMed ID: 34875107
[TBL] [Abstract][Full Text] [Related]
6. Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review.
Bohaumilitzky L; von Knebel Doeberitz M; Kloor M; Ahadova A
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32512823
[TBL] [Abstract][Full Text] [Related]
7. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
8. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.
Battaglin F; Naseem M; Lenz HJ; Salem ME
Clin Adv Hematol Oncol; 2018 Nov; 16(11):735-745. PubMed ID: 30543589
[TBL] [Abstract][Full Text] [Related]
10. An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome.
Therkildsen C; Jensen LH; Rasmussen M; Bernstein I
Clin Exp Gastroenterol; 2021; 14():181-197. PubMed ID: 34079322
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
13. Precision Medicine in the Era of Genetic Testing: Microsatellite Instability Evolved.
Ioffe D; McSweeny M; Hall MJ
Clin Colon Rectal Surg; 2024 May; 37(3):157-171. PubMed ID: 38617845
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of microsatellite instability across solid neoplasms].
Colle R; Cohen R
Bull Cancer; 2019 Feb; 106(2):114-118. PubMed ID: 30409467
[TBL] [Abstract][Full Text] [Related]
15. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.
Yamamoto H; Imai K
Semin Oncol; 2019 Jun; 46(3):261-270. PubMed ID: 31537299
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch repair in cancer.
Baretti M; Le DT
Pharmacol Ther; 2018 Sep; 189():45-62. PubMed ID: 29669262
[TBL] [Abstract][Full Text] [Related]
17. Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability.
Borelli B; Antoniotti C; Carullo M; Germani MM; Conca V; Masi G
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291761
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and patients treated for cancer with microsatellite instability.
Colle R; Cohen R; Cochereau D; Duval A; Lascols O; Lopez-Trabada D; Afchain P; Trouilloud I; Parc Y; Lefevre JH; Fléjou JF; Svrcek M; André T
Bull Cancer; 2017 Jan; 104(1):42-51. PubMed ID: 27979364
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and Treatment of MSI-H Cancer in Gynecological Cancer].
Yamamoto N; Tashiro H; Katabuchi H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1577-1581. PubMed ID: 30449841
[TBL] [Abstract][Full Text] [Related]
20. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
